Concentration-QT Study of Paroxetine in Healthy Adults

Clinical trial NCT06065735 · COMPLETED

Trial details

NCT number: NCT06065735
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Anxiety Disorders

Start date: 2023-10-02
Primary completion: 2024-01-08
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.